{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:45:18Z","timestamp":1741189518804,"version":"3.38.0"},"reference-count":38,"publisher":"JLE","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.nephro.2010.10.011","type":"journal-article","created":{"date-parts":[[2010,12,25]],"date-time":"2010-12-25T10:24:58Z","timestamp":1293272698000},"page":"86-91","source":"Crossref","is-referenced-by-count":1,"title":["Fer, hepcidine et insuffisance r\u00e9nale chronique"],"prefix":"10.1684","volume":"7","author":[{"given":"Patrick","family":"Fievet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Brazier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2010.10.011_bib0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ndt\/13.1.82","article-title":"Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium","volume":"13","author":"Kooistra","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.10.011_bib0010","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1093\/ndt\/13.10.2578","article-title":"The absorption of iron is disturbed in recombinant human erythropoietin-treated peritoneal dialysis patients","volume":"13","author":"Kooistra","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.10.011_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2215\/CJN.01670408","article-title":"Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988\u20132004","volume":"4","author":"Fishbane","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.10.011_bib0020","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1093\/ndt\/gfn267","article-title":"Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease","volume":"23","author":"Swinkels","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.nephro.2010.10.011_bib0025","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI0215686","article-title":"The gene encoding the iron regulatory peptide hepcidine is regulated by anemia, hypoxia and inflammation","volume":"110","author":"Nicolas","year":"2002","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.nephro.2010.10.011_bib0030","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6\u00a0mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nephro.2010.10.011_bib0035","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","article-title":"Immunoassay for human serum hepcidin","volume":"112","author":"Ganz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.10.011_bib0040","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1182\/blood-2004-12-4844","article-title":"Hepcidin in iron overload disorders","volume":"105","author":"Papanikolaou","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.10.011_bib0045","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to EPO therapy in renal disease","volume":"75","author":"Ashby","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.10.011_bib0050","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood-2006-06-027631","article-title":"Interleukin-6\u00a0induces hepcidin expression through Stat\u00a03","volume":"108","author":"Wrighting","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.10.011_bib0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MOH.0b013e3282f73335","article-title":"Iron regulation and erythropoiesis","volume":"15","author":"Nemeth","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.nephro.2010.10.011_bib0060","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1157121","article-title":"The serin protease TMPRSS6\u00a0is required to sense iron deficiency","volume":"320","author":"Du","year":"2008","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.nephro.2010.10.011_bib0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.tibs.2008.08.002","article-title":"HIF-1\u00a0regulation: not so easy come, easy go","volume":"33","author":"Koh","year":"2008","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.nephro.2010.10.011_bib0070","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1182\/blood-2008-12-195594","article-title":"Molecular mechanisms of the defective inhibition in TMPRSS6\u00a0mutations associated with iron deficiency","volume":"113","author":"Silvestri","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2010.10.011_bib0075","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15\u00a0in thalassemia suppress expression of the iron regulatory protein hepcidin","volume":"13","author":"Tanno","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.nephro.2010.10.011_bib0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000109968","article-title":"Association of prohepcidin and hepcidin\u00a025\u00a0with erythropoietin response and ferritin in hemodialysis patients","volume":"28","author":"Kato","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2010.10.011_bib0085","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/ndt\/gfp546","article-title":"Serum hepcidin-25\u00a0levels in patients with chronic kidney disease are independent of glomerular filtration rate","volume":"25","author":"Peters","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.10.011_bib0090","first-page":"758A","article-title":"FG-2216\u00a0increases hemoglobin concentration in anemic patients with chronic kidney disease (abstract SA-PO924)","volume":"16","author":"G\u00fcnzler","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.10.011_bib0095","doi-asserted-by":"crossref","first-page":"A-80","DOI":"10.1053\/j.ajkd.2008.02.222","article-title":"FG-2216\u00a0a novel oral HIF-PHI stimulates erythropo\u00efesis and increases hemoglobin concentration in patients with non-dialysis CKD (abstract\u00a0212)","volume":"51","author":"Provenzano","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.10.011_bib0100","first-page":"515A","article-title":"The prolylhydroxylase inhibitor FG-2216\u00a0stimulates EPO production in nephric and anephric dialysis patients (abstract SA-PO784)","volume":"18","author":"Bernhardt","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.10.011_bib0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.299.6692.157","article-title":"Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously","volume":"299","author":"Macdougall","year":"1989","journal-title":"Br Med J"},{"key":"10.1016\/j.nephro.2010.10.011_bib0110","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/ki.1996.487","article-title":"A randomized controlled study of iron supplementation in patients treated with erythropoietin","volume":"50","author":"Macdougall","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.10.011_bib0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ndt\/16.suppl_7.25","article-title":"Hyporesponsiveness to recombinant human erythropoietin","volume":"16","author":"Drueke","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.10.011_bib0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ndt\/gfl716","article-title":"Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients","volume":"22","author":"Rossert","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.10.011_bib0125","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nchembio807","article-title":"The role of iron regulatory proteins in mammalian iron homeostasis and disease","volume":"2","author":"Rouault","year":"2006","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.nephro.2010.10.011_bib0130","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1073\/pnas.93.16.8175","article-title":"Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxyde, and oxydative stress","volume":"93","author":"Hentze","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nephro.2010.10.011_bib0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/ajkd.2001.25203","article-title":"Optimizing erythropoietin therapy in haemodialysis patients","volume":"38","author":"Richardson","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.10.011_bib0140","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1681\/ASN.V113530","article-title":"Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients","volume":"11","author":"Besarab","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.10.011_bib0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0272-6386(99)70103-4","article-title":"A study of parenteral iron regimens in hemodialysis patients","volume":"34","author":"Besarab","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.10.011_bib0150","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the dialysis patients\u2019 response to IV iron with elevated ferritin (DRIVE) study","volume":"18","author":"Coyne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.10.011_bib0155","doi-asserted-by":"crossref","unstructured":"KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006;47:S58-70.","DOI":"10.1053\/j.ajkd.2006.03.011"},{"key":"10.1016\/j.nephro.2010.10.011_bib0160","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ndt\/gfn653","article-title":"Anaemia management in patients with chronic kidney disease: a position statement by the anaemia working group of European Renal Best Practice (ERBP)","volume":"24","author":"Locatelli","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.10.011_bib0165","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2008.05.033","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis","volume":"52","author":"Rozen-Zvi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.10.011_bib0170","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000035250.66458.67","article-title":"Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease","volume":"106","author":"Drueke","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2010.10.011_bib0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ndt\/gfg579","article-title":"Labile iron in parenteral iron formulations: a quantitative and comparative study","volume":"19","author":"Van Wyck","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.10.011_bib0180","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1592\/phco.27.3.343","article-title":"Comparison of oxydative stress markers after intravenous administration of iron dextran, sodium ferric gluconate and iron sucrose in patients undergoing dialysis","volume":"27","author":"Barton Pai","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.nephro.2010.10.011_bib0185","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ndt\/gfi253","article-title":"Update on adverse drug events associated with parenteral iron","volume":"21","author":"Chertow","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.10.011_bib0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/ajkd.1998.v31.pm9428456","article-title":"A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients","volume":"31","author":"Auerbach","year":"1998","journal-title":"Am J Kidney Dis"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725510002191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725510002191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2010.10.011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:00:26Z","timestamp":1741186826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725510002191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1769725510002191"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2010.10.011","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}